Pharmacokinetic and bioequivalence study of Telzap® Plus fixed-dose combination compared with MikardisPlus® in healthy volunteers after single administration by A. L. Khokhlov, A. A. Khokhlov, A. E. Miroshnikov, O. V. Lebedeva, D. Yu. Grebenkin

Get full text

The Impact of the EU’s Generalized System of Preferences Plus Status on Companies and Fiscal Policy of Pakistan: A Case of the Textile Industry by Choudhary Mazhar Hussain

Subjects: Get full text

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention by Johny Nicolas, Usman Baber, Roxana Mehran

“…The study enrolled 9,006 patients, of whom 7,119 who tolerated 3 months of dual antiplatelet therapy were randomized after 3 months into two arms: ticagrelor plus placebo and ticagrelor plus aspirin. …”
Get full text

Isolation and characterization of Methanosphaera sp. ISO3-F5, a member of a novel and widespread species of rumen methanogens growing with methanol plus hydrogen by Jeyamalar Jeyanathan, Nikola Palevich, Kerri Reilly, Faith P. Palevich, Paul H. Maclean, Dong Li, Eric Altermann, Caroline C. Kim, Inge Maartje van Scheepstal, Simone O. Hoskin, William J. Kelly, Sinead C. Leahy, Graeme T. Attwood, Ron S. Ronimus, Gemma Henderson, Peter H. Janssen

Get full text

Pretreatment CT-Based Machine Learning Radiomics Model Predicts Response in Inoperable Stage III NSCLC Treated with Concurrent Radiochemotherapy Plus PD-1 Inhibitors by Ya Li Bachelor, Min Zhang Bachelor, Yong Hu MM, Bo Du Bachelor, Youlong Mo Bachelor, Tianchu He MM, Mingdan Zhao Bachelor, Benlan Li Bachelor, Ji Xia Bachelor, Zhongjun Huang Bachelor, Fangyang Lu MD, Zhen Huang Bachelor, Bing Lu MD, Jie Peng MD

Get full text

Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort by Xichun Hu, Qingyuan Zhang, Tao Sun, Huihua Xiong, Wei Li, Yuee Teng, Yen-Shen Lu, Ling-Ming Tseng, Min Yan, Hongsheng Li, Danmei Pang, Shin-Cheh -Chen, Wenyan Chen, Ou Jiang, Jingfen Wang, Xinhong Wu, Xian Wang, Aimin Zang, Xiaojia Wang, Julie M. Collins, Ethan Fan, Lin Jiang, Xiaoling Zeng, Nicholas C. Turner

Get full text

J-PLUS: Tomographic analysis of galaxy angular density and redshift fluctuations in Data Release 3.... by Carlos Hernández-Monteagudo, A. Balaguera-Antolínez, R. von Marttens, A. del Pino, A. Hernán-Caballero, L. R. Abramo, J. Chaves-Montero, C. López-Sanjuan, V. Marra, E. Tempel, G. Aricò, J. Cenarro, D. Cristóbal-Hornillos, A. Marín-Franch, M. Moles, J. Varela, H. Vázquez Ramió, J. Alcaniz, R. Dupke, A. Ederoclite, L. Sodré Jr., R. E. Angulo

“…The <em>Javalambre Photometric Local Universe Survey</em> (J-PLUS) is a <em> spectro-photometric</em>survey covering about 3,000~deg$^2$ in its third data release (DR3), and containing about 300,000 galaxies with high quality ({\it odds}$>0.8$) photometric redshifts (hereafter photo-$z$s). …”
Get full text

Self-help plus and problem management plus – a qualitative study to assess acceptability and feasibility with rape and GBV survivors in South Africa by Samantha Willan, Zamakhoza Khoza, Sinqobile Mngadi, Jani Nothling, Thobeka Majola, Mpumelelo Mabhida, Tholsie Gounden, Mbalenhle Shabalala, Amanda Zembe, Gugu Gigaba, Rachel Jewkes, Naeemah Abrahams

“…This study adapted two WHO interventions, Self-Help Plus (SH+) and Problem Management Plus (PM+), both aim to strengthen coping, stress management skills and resilience, particularly in resource-limited contexts. …”
Get full text

Comparison between norepinephrine plus epinephrine and norepinephrine plus vasopressin after return of spontaneous circulation in patients with out-of-hospital cardiac arrest by Sejoong Ahn, Bo-Yeong Jin, Sukyo Lee, Jong-Hak Park, Hanjin Cho, Sungwoo Moon, Korean Cardiac Arrest Research Consortium (KoCARC) Investigators

“…Survival to discharge and good neurological outcome were significantly higher in the group with norepinephrine plus epinephrine than in the group with norepinephrine plus vasopressin (17.0% vs. 9.1%, p = 0.001, and 8.1% vs. 3.2%, p = 0.002, respectively). …”
Get full text

Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma. by Nicholas Brown, Catherine McBain, Stephen Nash, Kirsten Hopkins, Paul Sanghera, Frank Saran, Mark Phillips, Fiona Dungey, Laura Clifton-Hadley, Katharina Wanek, Daniel Krell, Sarah Jeffries, Iftekhar Khan, Paul Smith, Paul Mulholland

“…Median PFS with cediranib plus gefitinib was 3.6 months compared to 2.8 months for cediranib plus placebo (HR; 0.72, 90% CI; 0.41 to 1.26). …”
Get full text

Effect of an Energy-Restricted Mediterranean Diet, Physical Activity and Behavioral Support Lifestyle Intervention on Body Composition in Older Adults with Metabolic Syndrome: Three-Year Results of the PREDIMED-Plus Trial by Dora Romaguera, Miguel Ruiz-Canela, J. Alfredo Martínez, Vicente Martín, Ramón Estruch, Jordi Salas-Salvadó, Jadwiga Konieczna

“…Here, we aimed to evaluate the effect of an intensive nutritional and behavioral weight-loss intervention with an energy-restricted (er) Mediterranean Diet (MedDiet) on the changes in age-related overall and regional body composition objectively measured over three years. Methods: Body composition was measured with dual energy X-ray absorptiometry (DXA) in a subsample of 1521 participants (aged 55–75 years with overweight/obesity and metabolic syndrome) in the PREDIMED-Plus trial assigned (1:1) to multifactorial intervention with erMedDiet, increased physical activity (PA) and behavioral support (intervention) or usual care with advices to follow MedDiet without energy restriction or PA promotion (control group). …”
Get full text

Medical Image Segmentation for Anomaly Detection Using Deep Learning Techniques by Bibat Thokar, Binod Sapkota, Babu R. Dawadi, Shashidhar R. Joshi

Subjects: “…DeepLabv3plus…”
Get full text

Pedicel weight and length do not affect kiwifruit size by J. G. Cruz-Castillo, D. J. Woolley

Subjects: Get full text

First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial by Ying Cheng, Shuang Zhang, Liang Han, Lin Wu, Jun Chen, Peiyan Zhao, Hongmei Sun, Guilan Wen, Yinghua Ji, Anastasia Zimina, Jianhua Shi, Zhijie Pan, Jinsheng Shi, Xicheng Wang, Yuansong Bai, Tamar Melkadze, Yueyin Pan, Xuhong Min, Maksym Viguro, Xingya Li, Yanqiu Zhao, Junquan Yang, Tamta Makharadze, Ekaterine Arkania, Haoyu Yu, Jing Li, Fang Yang, Xinyi Yang, Chen Ling, Qingyu Wang, Yongqiang Shan, Jun Zhu, the ASTRUM‐005 Study Group

“…Abstract Background The ASTRUM‐005 study previously demonstrated a significant overall survival (OS) benefit with serplulimab (a programmed death 1 inhibitor) plus chemotherapy versus chemotherapy alone in previously untreated extensive‐stage small‐cell lung cancer (ES‐SCLC). …”
Get full text

Comparative Micro-CT Evaluation of Dentinal Tubule Penetration of BIO-C and AH Plus Jet Root Canal Sealer Using Three Intra-Canal Activation Techniques by K. Vivek, Sreeja Sreedhar, Siddharth V. Nair, V. Sreelekshmi, J. Jitha, Anitha Viswanadhan, P. M Athira

“…Objectives: This study aimed to compare the effectiveness of three intra-canal sealer activation techniques: ultrasonic, Lentulospiral activation, and GP cone-mediated ultrasonic activation on dentinal tubule penetration of a bioceramic (BIO-C) root canal sealer and AH Plus jet sealer with single cone obturation. …”
Get full text

Long-term efficacy and updated survival outcomes of sintilimab plus anlotinib in patients with PD-L1-positive recurrent or metastatic cervical cancer by Jing Liu, Chunyan Lan, Tongyu Liu, Qin Liu, Lele Chang, Lele Zang, Fei Zhu, Mingxuan Zhu, Huiqi Zhang, Yaxin Kang, Yuqin Wang, Huaiwu Lu, Yang Sun, Qin Xu

“…Here, we presented updated survival outcomes after a 3-year follow-up. Methods Patients received a regimen comprising 200 mg of sintilimab administered once on day 1 and 10 mg of anlotinib once daily on days 1–14 every 3 weeks. …”
Get full text

An exceptional cluster algebra for Higgs plus jet production by Rigers Aliaj, Georgios Papathanasiou

“…Abstract A recent evaluation of three-loop nonplanar Feynman integrals contributing to Higgs plus jet production has established their dependence on two novel symbol letters. …”
Get full text

Efficacy and safety of nanoparticle albumin-bound paclitaxel plus cisplatin or nedaplatin plus tegafur/gimeracil/oteracil as induction chemotherapy regimen for hypopharyngeal cance... by Cailing Jiang, Yulan Liu, Yunyan Mo, Lieyin Xu, Lin Zhu, Zhenya Li, Shengyuan Xu, Xi Qin, Guangteng Wu, Mafei Kang, Xiaosong He, Feng Xue

“…In this study, our objective was to retrospectively analyze the short-term efficacy and adverse events of nab-paclitaxel plus cisplatin or nedaplatin plus tegafur/gimeracil/oteracil as an induction chemotherapy regimen for hypopharyngeal cancer.MethodsThis retrospective study involved 19 patients who received nab-paclitaxel plus cisplatin/nedaplatin plus tegafur/gimeracil/oteracil every 21 days intervals for three cycles at the Affiliated Hospital of Guilin Medical University (December 2020 to February 2023). …”
Get full text

Accuracy of Truenat™ MTB Plus for the diagnosis of pulmonary TB by M.C.M. Melo, A.K. Silveira, A.P.R. Dalvi, J. Silva, V.S. Printes, L. Anselmo, T.I. da Silva, M.M. Oliveira, C. Conceição, A. Lopes, V. Bollela, M. Cordeiro-Santos, M. Bhering, A.S.R. Moreira, A.C.C. Carvalho, A.L. Kritski

“…Among 71 patients previously treated for TB, Truenat MTB Plus showed sensitivity and specificity of respectively 79.3% (95% CI 60.28–92.01) and 97.5% (95% CI 86.84–99.94). …”
Get full text

20-22 juin 2012 : Rio plus vain ? by Franck-Dominique Vivien

Get full text